Nucleus RadioPharma Appoints Former McKesson, Novo Nordisk Executive Kathy Spencer-Pike as Chief Commercial Officer to Drive Business Growth
Position
Chief Commercial Officer
Company
Nucleus RadioPharma
Description
Nucleus RadioPharma, a fully integrated development, manufacturing, and supply chain organization for radiopharmaceuticals, announced the appointment of Kathy Spencer-Pike as Chief Commercial Officer. As a seasoned veteran with decades of commercial experience at McKesson, Novo Nordisk, Sanofi and Pfizer, Spencer-Pike will be responsible for accelerating the growth of the startup following its oversubscribed $56M Series A in October.
Who to call at Nucleus RadioPharma, and when
A new leader at Nucleus RadioPharma brings new priorities and often new vendors. The first weeks are when they listen.
- An alert the day Nucleus RadioPharma raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Nucleus RadioPharma, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Nucleus RadioPharma. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Nucleus RadioPharma changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Nucleus RadioPharma changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.